{"DataElement":{"publicId":"3203127","version":"1","preferredName":"Gastroesophageal Reflux Disease Treatment Biospecimen Collection Timepoint Administered Type","preferredDefinition":"A chronic disorder characterized by reflux of the gastric and/or duodenal contents into the distal esophagus. It is usually caused by incompetence of the lower esophageal sphincter. Symptoms include heartburn and acid indigestion. It may cause injury to the esophageal mucosa._An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process._The act or process of gathering biospecimens for testing, diagnostic, propagation, treatment or research purposes._A specific point in the time continuum, including those established relative to an event._Given._Type; a subdivision of a particular kind of thing.","longName":"3203105v1.0:3203120v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3203105","version":"1","preferredName":"Gastroesophageal Reflux Disease Treatment Biospecimen Collection Timepoint Administered","preferredDefinition":"A chronic disorder characterized by reflux of the gastric and/or duodenal contents into the distal esophagus. It is usually caused by incompetence of the lower esophageal sphincter. Symptoms include heartburn and acid indigestion. It may cause injury to the esophageal mucosa._An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process._The act or process of gathering biospecimens for testing, diagnostic, propagation, treatment or research purposes._A specific point in the time continuum, including those established relative to an event._Given.","longName":"3203102v1.0:3203103v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3203102","version":"1","preferredName":"Gastroesophageal Reflux Disease Therapeutic Procedure","preferredDefinition":"A chronic disorder characterized by reflux of the gastric and/or duodenal contents into the distal esophagus. It is usually caused by incompetence of the lower esophageal sphincter. Symptoms include heartburn and acid indigestion. It may cause injury to the esophageal mucosa.:An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C26781:C49236","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastroesophageal Reflux Disease","conceptCode":"C26781","definition":"A chronic disorder characterized by reflux of the gastric and/or duodenal contents into the distal esophagus. It is usually caused by incompetence of the lower esophageal sphincter. Symptoms include heartburn and acid indigestion. It may cause injury to the esophageal mucosa.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-B3AF-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"WHITES","dateCreated":"2011-03-14","modifiedBy":"ONEDATA","dateModified":"2011-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3203103","version":"1","preferredName":"Biospecimen Collection Timepoint Administered","preferredDefinition":"The act or process of gathering biospecimens for testing, diagnostic, propagation, treatment or research purposes.:A specific point in the time continuum, including those established relative to an event.:Given.","longName":"C70945:C68568:C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biospecimen Collection","conceptCode":"C70945","definition":"The act or process of gathering biospecimens for testing, diagnostic, propagation, treatment or research purposes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Timepoint","conceptCode":"C68568","definition":"A specific point in the time continuum, including those established relative to an event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-B3C1-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"WHITES","dateCreated":"2011-03-14","modifiedBy":"ONEDATA","dateModified":"2011-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-B3D2-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"WHITES","dateCreated":"2011-03-14","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of S Ratliff 3/2011 sw.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3203120","version":"1","preferredName":"Gastroesophageal Reflux Disease Treatment Type","preferredDefinition":"A chronic disorder characterized by reflux of the gastric and/or duodenal contents into the distal esophagus. It is usually caused by incompetence of the lower esophageal sphincter. Symptoms include heartburn and acid indigestion. It may cause injury to the esophageal mucosa._An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process._Type; a subdivision of a particular kind of thing.","longName":"3203120v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"H2 Blockers","valueDescription":"Histamine-2 Receptor Antagonist","ValueMeaning":{"publicId":"3205590","version":"1","preferredName":"Histamine-2 Receptor Antagonist","longName":"3205590","preferredDefinition":"Any agent that competitively binds to and blocks the histamine-2 (H-2) receptor on the parietal cell in the stomach.  This prevens the secretion of gastric acid by parietal cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histamine-2 Receptor Antagonist","conceptCode":"C29702","definition":"Any agent that competitively binds to and blocks the histamine H2 receptors found in the stomach, heart, uterus, on vascular smooth muscle and in the central nervous system (CNS). Of particular clinical relevance is the blockage of H2 receptors found on the parietal cells of the stomach, which prevents gastric acid secretion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9EC85F3A-682D-2722-E040-BB89AD431894","latestVersionIndicator":"Yes","beginDate":"2011-03-18","endDate":null,"createdBy":"WHITES","dateCreated":"2011-03-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"TCGA:The Cancer Genome Atlas","id":"9EC85F3A-6845-2722-E040-BB89AD431894","beginDate":"2011-03-14","endDate":null,"createdBy":"WHITES","dateCreated":"2011-03-18","modifiedBy":"ONEDATA","dateModified":"2011-03-18","deletedIndicator":"No"},{"value":"Not Applicable","valueDescription":"Not Applicable","ValueMeaning":{"publicId":"2838911","version":"1","preferredName":"Not Applicable","longName":"2838911","preferredDefinition":"Determination that a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62AB59ED-A641-4EBE-E040-BB89AD4348C8","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"CLOHNES","dateModified":"2022-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9E750F66-B435-C16C-E040-BB89AD4352EB","beginDate":"2011-03-14","endDate":null,"createdBy":"WHITES","dateCreated":"2011-03-14","modifiedBy":"ONEDATA","dateModified":"2011-03-14","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9E750F66-B43F-C16C-E040-BB89AD4352EB","beginDate":"2011-03-14","endDate":null,"createdBy":"WHITES","dateCreated":"2011-03-14","modifiedBy":"ONEDATA","dateModified":"2011-03-14","deletedIndicator":"No"},{"value":"Antacids","valueDescription":"Antacid Preparation","ValueMeaning":{"publicId":"3203122","version":"1","preferredName":"Antacid Preparation","longName":"3203122","preferredDefinition":"Natural or synthetic compounds or mixtures, Antiacid Preparations such as sodium bicarbonate, sodium citrate, and phosphate salts act as proton acceptors, neutralizing the acidity of a biologic environment (skin, gastric content, urine, etc.) and raising the pH. These agents are used topically or systemically for management of metabolic acidosis, improved muscle contraction, and hyper-acidic conditions (preventing, counteracting, or neutralizing stomach acidity). (NCI04)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Antacid Preparation","conceptCode":"C29633","definition":"Natural or synthetic compounds or mixtures, Antiacid Preparations such as sodium bicarbonate, sodium citrate, and phosphate salts act as proton acceptors, neutralizing the acidity of a biologic environment (skin, gastric content, urine, etc.) and raising the pH. These agents are used topically or systemically for management of metabolic acidosis, improved muscle contraction, and hyper-acidic conditions (preventing, counteracting, or neutralizing stomach acidity). (NCI04)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-B44C-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"WHITES","dateCreated":"2011-03-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"TCGA:The Cancer Genome Atlas","id":"9E750F66-B465-C16C-E040-BB89AD4352EB","beginDate":"2011-03-14","endDate":null,"createdBy":"WHITES","dateCreated":"2011-03-14","modifiedBy":"ONEDATA","dateModified":"2011-03-14","deletedIndicator":"No"},{"value":"Proton Pump Inhibitors","valueDescription":"Proton Pump Inhibitor","ValueMeaning":{"publicId":"3203126","version":"1","preferredName":"Proton Pump Inhibitor","longName":"3203126","preferredDefinition":"Any one of the substituted benzimidazole compounds with anti-ulcer activity. A proton pump inhibitor is orally administered in the neutrally charged, inactive form and, upon entering the acidic environment of the parietal cell, gets protonated and converted into its active form. The active form will covalently and irreversibly bind to the proton pump, the H+/K+-ATPase, located on the surface of parietal cells. This leads to an inhibition of the transport of hydrogen ions, in exchange for potassium ions, into the gastric lumen and results in an inhibition of gastric acid secretion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Proton Pump Inhibitor","conceptCode":"C29723","definition":"Any one of the substituted benzimidazole compounds with anti-ulcer activity. A proton pump inhibitor is orally administered in the neutrally charged, inactive form and, upon entering the acidic environment of the parietal cell, gets protonated and converted into its active form. The active form will covalently and irreversibly bind to the proton pump, the H+/K+-ATPase, located on the surface of parietal cells. This leads to an inhibition of the transport of hydrogen ions, in exchange for potassium ions, into the gastric lumen and results in an inhibition of gastric acid secretion.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-B498-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"WHITES","dateCreated":"2011-03-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"TCGA:The Cancer Genome Atlas","id":"9E750F66-B4B1-C16C-E040-BB89AD4352EB","beginDate":"2011-03-14","endDate":null,"createdBy":"WHITES","dateCreated":"2011-03-14","modifiedBy":"ONEDATA","dateModified":"2011-03-14","deletedIndicator":"No"},{"value":"No Treatment","valueDescription":"None","ValueMeaning":{"publicId":"2577064","version":"1","preferredName":"None","longName":"2577064","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA15-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-22","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE12571D-085D-9ACA-E040-BB89AD4324C1","beginDate":"2012-04-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-19","modifiedBy":"ONEDATA","dateModified":"2012-04-19","deletedIndicator":"No"},{"value":"Surgically Treated","valueDescription":"Surgical Procedure","ValueMeaning":{"publicId":"3440172","version":"1","preferredName":"Surgical Procedure","longName":"3440172","preferredDefinition":"A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Surgical Procedure","conceptCode":"C15329","definition":"A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE12571D-0867-9ACA-E040-BB89AD4324C1","latestVersionIndicator":"Yes","beginDate":"2012-04-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-19","modifiedBy":"KUMMEROA","dateModified":"2024-02-22","changeDescription":"Added OBIB alternate name and identifier DW 03-21-2019","administrativeNotes":"2023.1.20 Alt VM added per ticket request CADSR0001943. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE12571D-087F-9ACA-E040-BB89AD4324C1","beginDate":"2012-04-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-19","modifiedBy":"ONEDATA","dateModified":"2012-04-19","deletedIndicator":"No"},{"value":"Medically Treated","valueDescription":"Medical Therapeutic Procedure","ValueMeaning":{"publicId":"3440173","version":"1","preferredName":"Medical Therapeutic Procedure","longName":"3440173","preferredDefinition":"Medical; relating to the study or practice of medicine.: An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medical","conceptCode":"C25261","definition":"Relating to the study or practice of medicine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE12571D-088D-9ACA-E040-BB89AD4324C1","latestVersionIndicator":"Yes","beginDate":"2012-04-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE12571D-08A6-9ACA-E040-BB89AD4324C1","beginDate":"2012-04-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-19","modifiedBy":"ONEDATA","dateModified":"2012-04-19","deletedIndicator":"No"},{"value":"Not Reported","valueDescription":"Not Reported","ValueMeaning":{"publicId":"2572231","version":"1","preferredName":"Not Reported","longName":"2572231","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E734-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-11-16","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"676723E0-DBDE-2A64-E053-F662850AEC4B","beginDate":"2018-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-14","modifiedBy":"ONEDATA","dateModified":"2018-03-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3203119","version":"1","preferredName":"Gastroesophageal Reflux Disease Therapeutic Procedure Type","preferredDefinition":"A chronic disorder characterized by reflux of the gastric and/or duodenal contents into the distal esophagus. It is usually caused by incompetence of the lower esophageal sphincter. Symptoms include heartburn and acid indigestion. It may cause injury to the esophageal mucosa.:An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.:Type; a subdivision of a particular kind of thing.","longName":"C26781:C49236:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastroesophageal Reflux Disease","conceptCode":"C26781","definition":"A chronic disorder characterized by reflux of the gastric and/or duodenal contents into the distal esophagus. It is usually caused by incompetence of the lower esophageal sphincter. Symptoms include heartburn and acid indigestion. It may cause injury to the esophageal mucosa.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-B40F-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"WHITES","dateCreated":"2011-03-14","modifiedBy":"ONEDATA","dateModified":"2011-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-B420-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"WHITES","dateCreated":"2011-03-14","modifiedBy":"COOPERM","dateModified":"2018-03-14","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of S Ratliff 3/2011 sw. Added PVs per request by T.Lichtenberg. mc 4/19/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044924","version":"1","longName":"Inactive CDEs as of March 2017","context":"NCIP"}]},{"publicId":"3787498","version":"1","longName":"TCGA 2.6 by Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3787520","version":"1","longName":"STAD","context":"NCIP"}]},{"publicId":"5806857","version":"1","longName":"HCMI (Human Cancer Models Initiative)","context":"OCG","ClassificationSchemeItems":[{"publicId":"10000437","version":"1","longName":"Stomach","context":"OCG"}]}],"AlternateNames":[{"name":"antireflux_treatment_type","type":"TCGA_XML_Name","context":"NCIP"},{"name":"OCG","type":"USED_BY","context":"OCG"},{"name":"antireflux_treatment_type","type":"HCMI Name","context":"OCG"}],"ReferenceDocuments":[{"name":"If Patient Was Receiving Anti","type":"Preferred Question Text","description":"If Patient Was Receiving Anti-Reflux Treatment at Time of Sample Procurement; What Type of Treatment Was Being Given","url":null,"context":"NCIP"},{"name":"HCMI Question Text","type":"Alternate Question Text","description":"If patient was receiving anti-reflux treatment at time of sample procurement, what type of treatment was being given?","url":null,"context":"OCG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-B4BB-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"WHITES","dateCreated":"2011-03-14","modifiedBy":"TSESU","dateModified":"2018-07-17","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of S Ratliff 3/2011 sw.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}